Page 16 - Read Online

Page 454 Aledo-Serrano et al. J Transl Genet Genom 2021;5:443-55 https://dx.doi.org/10.20517/jtgg.2021.40

therapies. Neurology 2021;10.1212/WNL.0000000000012744. DOI PubMed
20. Scala M, Efthymiou S, Sultan T, et al. Homozygous SCN1B variants causing early infantile epileptic encephalopathy 52 affect
voltage-gated sodium channel function. Epilepsia 2021;62:e82-7. DOI PubMed
21. Song M, Liu J, Yang Y, Lv L, Li W, Luo XJ. Genome-wide meta-analysis identifies two novel risk loci for epilepsy. Front Neurosci
2021;15:722592. DOI PubMed PMC
22. Symonds JD, Zuberi SM. Genetics update: monogenetics, polygene disorders and the quest for modifying genes. Neuropharmacology
2018;132:3-19. DOI PubMed
23. Perucca P, Bahlo M, Berkovic SF. The genetics of epilepsy. Annu Rev Genomics Hum Genet 2020;21:205-30. DOI PubMed
24. Takata A, Nakashima M, Saitsu H, et al. Comprehensive analysis of coding variants highlights genetic complexity in developmental
and epileptic encephalopathy. Nat Commun 2019;10:2506. DOI PubMed PMC
25. Greenberg DA, Stewart WC. How should we be searching for genes for common epilepsy? Epilepsia 2012;53 Suppl 4:72-80. DOI
PubMed PMC
26. Leu C, Stevelink R, Smith AW, et al; Epi25 Consortium. Polygenic burden in focal and generalized epilepsies. Brain 2019;142:3473-
81. DOI PubMed PMC
27. Liu X, Shen Q, Zheng G, et al. Gene and phenotype expansion of unexplained early infantile epileptic encephalopathy. Front Neurol
2021;12:633637. DOI PubMed PMC
28. Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017;542:433-
8. DOI PubMed PMC
29. Allen AS, Berkovic SF, Cossette P, et al; Epi4K Consortium, Epilepsy Phenome/Genome Project. De novo mutations in epileptic
encephalopathies. Nature 2013;501:217-21. DOI PubMed PMC
30. Milh M, Villeneuve N, Chouchane M, et al. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy
and STXBP1 mutations. Epilepsia 2011;52:1828-34. DOI PubMed
31. Wild B, Nelson S. STXBP1-related developmental and epileptic encephalopathy. Pediatr Neurol Briefs 2019;33:6. DOI PubMed
PMC
32. Abramov D, Guiberson NGL, Burré J. STXBP1 encephalopathies: clinical spectrum, disease mechanisms, and therapeutic strategies. J
Neurochem 2021;157:165-78. DOI PubMed PMC
33. Suri M, Evers JMG, Laskowski RA, et al; DDD Study. Protein structure and phenotypic analysis of pathogenic and population
missense variants in STXBP1. Mol Genet Genomic Med 2017;5:495-507. DOI PubMed PMC
34. Liu X, Sun X, Sun C, et al. Prevalence of epilepsy in autism spectrum disorders: a systematic review and meta-analysis. Autism
2021:13623613211045029. DOI PubMed
35. Swietlik EM, Prapa M, Martin JM, et al. 'There and back again'-forward genetics and reverse phenotyping in pulmonary arterial
hypertension. Genes (Basel) 2020;11:1408. DOI PubMed PMC
36. Samanta D. PCDH19-related epilepsy syndrome: a comprehensive clinical review. Pediatr Neurol 2020;105:3-9. DOI PubMed
37. Aledo-Serrano Á, Del Ser T, Gil-Nagel A. Antiseizure medication withdrawal in seizure-free patients with PCDH19-related epilepsy: a
multinational cohort survey. Seizure 2020;80:259-61. DOI PubMed
38. Sadleir LG, Kolc KL, King C, et al. Levetiracetam efficacy in PCDH19 girls clustering epilepsy. Eur J Paediatr Neurol 2020;24:142-
7. DOI PubMed
39. Chakravorty S, Hegde M. Gene and variant annotation for mendelian disorders in the era of advanced sequencing technologies. Annu
Rev Genomics Hum Genet 2017;18:229-56. DOI PubMed
40. Sayers EW, Beck J, Bolton EE, et al. Database resources of the national center for biotechnology information. Nucleic Acids Res
2021;49:D10-7. DOI PubMed PMC
41. Byrne S, Enright N, Delanty N. Precision therapy in the genetic epilepsies of childhood. Dev Med Child Neurol 2021. DOI PubMed
42. Sobreira NLM, Arachchi H, Buske OJ, et al; Matchmaker Exchange Consortium. Matchmaker exchange. Curr Protoc Hum Genet
2017;95:9.31.1-9.31.15. DOI PubMed PMC
43. Wohler E, Martin R, Griffith S, et al. PhenoDB, GeneMatcher and VariantMatcher, tools for analysis and sharing of sequence data.
Orphanet J Rare Dis 2021;16:365. DOI PubMed PMC
44. Azzariti DR, Hamosh A. Genomic data sharing for novel mendelian disease gene discovery: the matchmaker exchange. Annu Rev
Genomics Hum Genet 2020;21:305-26. DOI PubMed
45. Møller RS, Hammer TB, Rubboli G, Lemke JR, Johannesen KM. From next-generation sequencing to targeted treatment of non-
acquired epilepsies. Expert Rev Mol Diagn 2019;19:217-28. DOI PubMed
46. Aledo-Serrano Á, Gómez-Iglesias P, Toledano R, et al. Sodium channel blockers for the treatment of epilepsy in CDKL5 deficiency
disorder: findings from a multicenter cohort. Epilepsy Behav 2021;118:107946. DOI PubMed
47. Wu AC, McMahon P, Lu C. Ending the diagnostic odyssey - is whole-genome sequencing the answer? JAMA Pediatr 2020;174:821-2.
DOI PubMed PMC
48. Espinosa-Jovel C, Toledano R, Aledo-Serrano Á, García-Morales I, Gil-Nagel A. Epidemiological profile of epilepsy in low income
populations. Seizure 2018;56:67-72. DOI PubMed
49. Raspa M, Moultrie R, Toth D, Haque SN. Barriers and facilitators to genetic service delivery models: scoping review. Interact J Med
Res 2021;10:e23523. DOI PubMed PMC
50. Aledo-Serrano A, García-Morales I, Toledano R, et al. Diagnostic gap in genetic epilepsies: a matter of age. Epilepsy Behav
2020;111:107266. DOI PubMed
51. Richards S, Aziz N, Bale S, et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of